Central mechanisms in the control of penile erection: Current theory and research

Neuroscience and Biobehavioral Reviews

Volumn 24, Issue 5, 2000, Pages 503-505

  Rosen, Raymond C ^a   Sachs, Benjamin D ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; NEUROTRANSMITTER;

DOPAMINERGIC SYSTEM; EDITORIAL; ERECTILE DYSFUNCTION; HUMAN; MALE; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; THEORY;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MALE; PENILE ERECTION; SPINAL CORD;

EID: 0034048004     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(00)00018-X     Document Type: Editorial

References (17)

1. K.-E. Anderson Pharmacology of lower urinary tract smooth muscles and penile erectile tissues Pharmacol Rev 45 1993 253 308
2. A.B. Araujo R. Durante H.A. Feldman I. Goldstein J. McKinlay The relationship between depressive symptoms and male erectile dysfunction Psychosom Med 60 1998 458 465
3. A.L. Burnett The role of nitric oxide in the physiology of erection Biol Reprod 52 1995 485 489
4. W.W. Dinsmore M. Hodges C. Hargreaves I.H. Osterloh M.D. Smith R.C. Rosen Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects Urology 53 1999 800 805
5. H.A. Feldman I. Goldstein D.G. Hatzichristou R.J. Krane J.B. McKinlay Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
6. I. Goldstein T.F. Lue H. Padma-Nathan R.C. Rosen W.D. Steers P.A. Wicker Oral sildenafil in the treatment of erectile dysfunction N Engl J Med 338 1998 1397 1404
7. J.P.W. Heaton A. Morales M.A. Adams B. Johnston R. El-Rashidy Recovery of erectile function by the oral administration of apomorphine Urology 45 1995 200 206
8. J.T. Korpelainen J.T. Kaubanen H. Kemola U. Malienen V.V. Myllyla Sexual dysfunction in stroke patients Acta. Neurol. Scand. 98 1998 400 405
9. E.O. Laumann A. Paik R.C. Rosen Sexual dysfunction in the United States: prevalence and predictors JAMA 281 1999 537 544
10. Linet OI, Ogrinc FG (for the Alprostadil Study Group). Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med 1996;334:873–877.
11. NIH Consensus Development Panel on Impotence. Impotence: NIH Consensus Conference. JAMA, 1993:270:83–90.
12. H. Padma-Nathan S. Auerbach R. Lewis The Apomorphine Study Group Efficacy and safety of apomorphine SL vs. placebo for male erectile dysfunction J Urol 161 1999 S214
13. H. Padma-Nathan W. Hellstrom F.E. Kaiser R.F. Labasky T.F. Lue W.E. Nolten P.C. Norwood C.A. Peterson R. Shabsigh P.Y. Tam Treatment of men with erectile dysfunction with transurethral alprostadil N Engl J Med 336 1997 1 7
14. J. Rajfer W.J. Aronson P.A. Bush F.J. Dorey L.J. Ignarro Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission N Engl J Med 326 1992 90 94
15. R.C. Rosen R.M. Lane M. Menza Effects of SSRIs on sexual function: a critical review J Clin Psychopharmacol 19 1999 67 85
16. R.T. Segraves M. Bari K. Segraves P. Spirnak Effect of apomorphine on penile tumescence in men with psychogenic impotence J Urol 145 1991 1174 1175
17. R.T. Segraves Treatment-emergent sexual dysfunction in affective disorder: a review and management strategies J Clin Psychiatry Monogr 11 1993 57 60